ABEONA THERAPEUTICS INC. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-05-25

Reporting Person: Mann Paul Elliot (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-25	Common Stock	A	38590	—	Acquired	38590	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-25	Stock Option (right to buy)	$1.49	A	49084	Acquired	2031-05-25	Common Stock (49084)	Direct

Footnotes

F1: All of the restricted stock will vest on November 25, 2021.

F2: All of the stock options will vest on November 25, 2021.